Actimmune (interferon gamma-1b) — United Healthcare
Severe, malignant osteopetrosis
Initial criteria
- Diagnosis of severe, malignant osteopetrosis
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Actimmune
Approval duration
12 months